Macrophage-VSMC Interaction Analysis Service
Background What We Can Offer Workflow Publication Why Choose Us FAQs Customer Review Related Services Contact Us
Atherosclerosis and aortic aneurysms are increasingly recognized as products of a dysfunctional cellular "dialogue." Creative Biolabs provides a definitive solution for researchers targeting these pathologies by delivering high-resolution mapping of the IL-1β/STAT3 signaling axis, CD36-mediated lipid dynamics, and the protective role of TREM2high macrophages. By dissecting these interactions, we help you determine whether your candidate molecule can prevent the pathological "macrophage-like" switch in vascular smooth muscle cells (VSMCs) or promote cholesterol efflux in VSMC-derived foam cells.
The Scientific Frontier of Macrophage-VSMC Crosstalk
The pathogenesis of atherosclerosis is no longer viewed as a simple lipid-deposition event, but as a complex "molecular dialogue" where macrophage-derived factors dictate the functional fate of VSMCs. Recent landmark studies highlight that macrophages secrete specialized exosomes and IL-1β to induce a phenotypic switch in VSMCs, leading to foam cell formation and structural destabilization. Our service targets these definitive molecular checkpoints, including the Nitro-redox axis, the STAT3 pathway, and CD36-mediated lipid dynamics, to provide a comprehensive platform for vascular drug discovery.
Comprehensive Capabilities in Vascular Crosstalk
Creative Biolabs offers an industry-leading suite of specialized platforms designed to capture the complexity of the vascular microenvironment. Beyond standard assays, we provide deep mechanistic insights into the following areas:
Phenotypic Fate Mapping & Lineage Tracing
We utilize a combination of scRNA-seq and multi-color flow cytometry to map the "transdifferentiation" of VSMCs. By tracking the loss of contractile markers like ACTA2 and the gain of macrophage markers like CD68 or LGALS3, we provide a quantitative assessment of how your drug candidate influences cellular identity and plaque stability.
Exosomal Signaling & miRNA Profiling
Our platform excels at isolating and characterizing macrophage-derived exosomes (Mφ-Exos). We analyze the regulatory cargo, such as miR-16-5p, which is known to target the SMAD7 pathway and drive VSMC synthetic switching. This capability is essential for clients developing RNA-based therapeutics or exosome-targeted biologics.
Nitro-Redox & Metabolic Stress Analysis
The vascular wall is highly sensitive to the NO/Nitro-redox axis. Creative Biolabs offers specialized assays to measure S-nitrosation of signaling proteins and the biphasic effects of nitric oxide on VSMC quiescence. This metabolic perspective is crucial for identifying targets that resolve oxidative stress-induced inflammation.
Advanced Aortic Architecture Models
Our "Triple-Layer" co-culture systems integrate intima macrophages, media VSMCs, and adventitia fibroblasts. This allows us to monitor the recruitment of monocytes via CCL2 and IL-8 gradients, offering a holistic view of the inflammatory cycle that simpler models cannot replicate.
Transform Your Vascular Research Strategy - Request a Technical Consultation with Our Scientists
Workflow
Creative Biolabs has developed a standardized yet flexible workflow that integrates cutting-edge multi-omics with functional validation.
Publication
This review comprehensively examines the molecular interactions between VSMCs and macrophages in atherosclerosis, a major cause of cardiovascular disease. It highlights how lipid accumulation, inflammation, and cellular crosstalk drive plaque formation and progression. The article discusses phenotypic switching of VSMCs, macrophage activation, and their communication via soluble factors, extracellular vesicles, and direct contact. It also evaluates current experimental models and identifies limitations, emphasizing the importance of these interactions as potential therapeutic targets.
Fig.1 Paracrine signaling between macrophages and VSMCs drives atherosclerotic progression. 1
Why Choose Us?
Creative Biolabs stands at the forefront of vascular biology, offering a unique "nitro-redox to single-cell" platform that provides unparalleled depth for drug discovery. Our technical advantage is grounded in published data demonstrating that targeting specific macrophage subsets or modulating the NO/Nitro-redox axis can significantly limit necrotic core expansion and enhance plaque stability. By integrating the latest research, such as the critical role of TREM2+ resident macrophages and adventitial fibroblasts, we ensure your project utilizes the most sophisticated scientific paradigms currently available. Our multidisciplinary team combines advanced bioinformatic modeling with robust functional assays, ensuring that every result is biologically relevant and translatable.
Experience the Creative Biolabs Competitive Edge - Partner with Us for Your Next Breakthrough
FAQs
Q1: How do you distinguish between macrophage-derived and VSMC-derived foam cells?
A1: We employ dual-marker immunofluorescence (α-SMA/CD68) combined with lineage-specific transcriptomic signatures to precisely identify the origin of lipid-laden cells.
Q2: What is the advantage of your "triple-cell" model over standard co-cultures?
A2: Our model includes adventitial fibroblasts, allowing for the study of the full "triple-layer" inflammatory recruitment involving CCL2 and IL-8, which is often missed in simpler models.
Q3: How do you ensure the stability of the VSMC phenotype in vitro?
A3: We utilize specialized, non-proliferative media and low-passage primary cells to minimize "culture-induced" phenotypic switching before your experimental induction begins.
Customer Review
-
Reliable Nitro-Redox Data
The S-nitrosation profiling provided by the team allowed us to compare our antioxidant leads with standard-of-care statins effectively. The precision was beyond our internal capabilities. - Prof. Sar** W
-
Superior Foam Cell Analysis
Their ability to distinguish between myeloid and VSMC-derived foam cells via ABCA1 expression profiles helped us pivot our project toward a more effective target before therapeutic trials. - Dr. J**nic B
Related Services
Creative Biolabs inhibits monocyte recruitment by targeting the CCL2-CCR2, CX3CL1-CX3CR1, and CSF1-CSF1R axes. We quantify TAM infiltration and M2 polarization to evaluate metastatic suppression and identify therapeutic candidates.
Learn More →
Creative Biolabs analyzes M1 polarization via ELISA, IHC, and flow cytometry. We quantify pro-inflammatory cytokines, ROS/RNI production, and surface markers (CD80/86) to evaluate pathogen clearance and Th1 activation efficiency.
Learn More →
How to Contact Creative Biolabs
The interaction between macrophages and VSMCs is the definitive frontier of cardiovascular medicine. Whether you are developing exosome-based therapeutics, monoclonal antibodies, or small-molecule modulators of cell death (ferroptosis/pyroptosis), our service provides the evidentiary foundation your program requires.
Contact Our Expert Team to Discuss Your Project Goals and Accelerate Your Research
Reference
-
Beck-Joseph, Jahnic, Maryam Tabrizian, and Stephanie Lehoux. "Molecular interactions between vascular smooth muscle cells and macrophages in atherosclerosis." Frontiers in Cardiovascular Medicine 8 (2021): 737934. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fcvm.2021.737934
